[{"Assets_0_Q3_USD":11310800000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":298300000.0,"NetIncomeLoss_1_Q3_USD":92200000.0,"NetIncomeLoss_3_Q3_USD":165100000.0,"StockholdersEquity_0_Q3_USD":5758800000.0,"EarningsPerShareBasic_1_Q3_USD":0.68,"EarningsPerShareBasic_3_Q3_USD":1.21,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":136000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":136000000.0,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20191106"}]